Thymosin α1

胸腺素α1

Report date: 2025/08/06 20:01:14

Base Information

Drug NameThymosin α1
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionThymosin receptor agonists
TargetsThymosin receptor
Therapy Area/IndicationsAortic DiseasesSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNanjing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Medical UniversitySun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsAortic DiseasesSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A